// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Assessing colour vision in the clinic: when is it useful and could we do better

Gordon Plant - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Glaucoma surgery: how to manage failing MIGS

Alastair Porteous - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

How to manage the failing tube

Faisal Ahmed - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Insights into the Farnsworth D15 test and its efficacy in occupational protocols

Benjamin Evans - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing the severity of colour vision loss – implications for occupational environments

John L. Barbur - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

One or many? Are there benefits for using test batteries for the classification of congenital colour vision deficiencies?

Gabriele Jordan - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Strategies to improve corneal endothelial graft outcomes

Hannah Levis - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Integrating exome and whole genome analysis with the Human Phenotype Ontology for discovery of new genes in rare eye diseases

Nikolas Pontikos - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Longitudinal morphological assessment of macular changes in glaucoma

Stefano Mercuri - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Longitudinal data of static and dynamic retinal vessel parameters

Rebekka Heitmar - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Intraoperative OCT guided peeling of ERM

Odysseas Georgiadis - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The challenge of optimising topical ocular formulations

Clive Clive Wilson - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

cyclopentolate Ophthalmic

Anti‐AQP4 and anti‐MOG optic neuropathies

Patrick Yu-Wai-Man - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Neuromyelitis optica

N/A

Evaluation of ganglion cell death: implications for therapy

M. Francesca Cordeiro - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Glaucoma genetics: Can we predict who will get glaucoma, and response to treatment?

Chris Hammond - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma, normal pressure

Prostaglandin

The London Project at 10 years: Have we found a cure?

Pete Coffey - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Age-Related Macular Degeneration

N/A

Changes in cell density as an early marker for low dose ionising radiation‐ induced cataractogenesis

Alice Uwineza - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract

N/A

The concept of cataratogenic load to understand ageing and radiation‐induced damage to the lens

Roy Quinlan - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract

N/A

Surgical management of neurotrophic keratopathy

Alex Shortt - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Ulcerative keratitis

N/A

Phaco it

Alastair Porteous - European Association for Vision and Eye Research (EVER) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract

N/A

Copyright © 2026. QuantiNova All rights reserved